- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03798392
Self-pressurised Air-Q With Blocker Versus Baska Mask in Low Risk Female Patients Undergoing Ambulatory Surgery.
A Randomized Comparison of Self-pressurized Air-Q With Blocker With Baska Mask Supraglottic Airway in Low Risk Female Patients Undergoing Ambulatory Surgery.
Supraglottic airway devices (SGAs) are very commonly used during anesthesia but structural vulnerability to airway morbidity and issues about cuff pressure still concern anesthesiologists. There have been controversial results regarding optimal intra-cuff pressure in various types of cuffed supraglottic airways. When the supraglottic cuff pressure is more than the mucosal perfusion pressure, it is likely to either cause postoperative pharyngo-laryngeal symptoms like sore throat (dysphagia, dysphonia) or cause local mucosal trauma and nerve injuries. Supraglottic airway devices with non-inflatable cuff have advantages in omitting the cuff pressure monitoring and reducing potential pharyngo-laryngeal complications.
Self-pressurizing Air Q blocker is the latest version. It has a drain tube through which a suction tube is passed. There is an inflatable cuff at the end of this tube. On inflation, the cuff seals the esophageal opening into the stomach, preventing any regurgitation of stomach contents. Instead of the pilot balloon and inflating cuff, the air-Q SP with blocker has a communication orifice at the junction of the peri-glotic cuff and the airway tube. This communication between two spaces enables the cuff to dynamically regulate intra-cuff pressure depending on airway pressure. This distinguishing feature of the air-Q SP may result in reduced risk for airway morbidities related to cuff hyperinflation.
The Baska mask is a novel supraglottic airway device with a non-inflatable cuff, an oesophageal drainage inlet and side channels to facilitate aspiration of gastric contents, and an integrated bite-block. It was revealed that the baska mask is relatively easy to insert, provided a high-quality seal with the glotic aperture and the incidence of throat discomfort appeared low.
To our knowledge, and after searching in previous literature, no previous studies have compared the Air-Q SP with blocker with Baska mask; another supraglottic airway devices with non-inflatable cuff.
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Abeer Ahmed, MD
- Phone Number: 01005244590
- Email: abeer_ahmed@kasralainy.edu.eg
Study Locations
-
-
-
Cairo, Egypt, 00225
- Recruiting
- Kasr Alainy Faculty of Medicine - Cairo university
-
Contact:
- Abeer Ahmed, Assistant Professor
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Female patients between the age group of 18 and 50 years,
- ASA class I and II,
- undergoing elective surgeries,
- with Ganzouri airway score less than 4
Exclusion Criteria:
- ASA III - V patients.
- Airway score ≥ 4 according to El-Ganzouri Airway Scoring System.
- Patients with respiratory or pharyngeal pathology.
- Patients allergic to any drugs in the protocol.
- Obese patients with body mass index ≥ 40.
- Patients known to have risk of gastric aspiration, gastro-esophageal reflux disease, hiatus hernia or previous upper gastrointestinal tract surgery.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: SP group
|
comparing the airway seal pressure 10 min after insertion of each devices .
Other Names:
|
Active Comparator: Baska group
|
comparing the airway seal pressure 10 min after insertion of each devices .
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
airway seal pressure 10 minutes after insertion
Time Frame: 10 minutes after the device insertion.
|
10 minutes after the device insertion.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- N-24- 2018
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Supraglottic Airway Devices
-
Istanbul Medeniyet UniversityCompletedSupraglottic Airway DevicesTurkey
-
Reham Ali Abdelhaleem AbdelrahmanCompleted
-
Yonsei UniversityCompletedGeneral Anesthesia | Supraglottic Airway DevicesKorea, Republic of
-
Hospital Clinic of BarcelonaAmbu A/SCompletedAirway Management | Laparoscopy | Supraglottic Airway DevicesSpain
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompleted
-
The University of Texas Health Science Center,...Ambu A/SCompleted
-
Cancer Institute and Hospital, Chinese Academy...UnknownSupraglottic AirwayChina
-
The University of Texas Health Science Center,...CompletedEndotracheal Intubation | Supraglottic AirwayUnited States
-
University of MalayaUnknownGeneral Anesthesia | Supraglottic Airway Device | Laryngeal Mask Airway
-
Yonsei UniversityCompletedSupraglottic Airway DeviceKorea, Republic of